| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |